U.S. market Closed. Opens in 4 minutes

SNOA | Sonoma Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2024-03-312023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-312012-03-312011-03-312010-03-312009-03-312008-03-312007-03-312006-03-312005-03-312004-03-312003-03-312002-03-31
Revenue12.73M13.27M12.63M18.63M18.94M18.97M16.66M12.82M15.08M13.85M13.67M15.45M12.74M9.75M7.36M5.39M3.83M4.54M2.58M1.36M902.00K2.47M2.00M
Cost of Revenue7.99M8.79M8.63M12.07M10.60M10.09M9.35M7.16M7.87M6.57M5.27M4.71M4.03M3.61M3.49M2.59M2.75M3.00M4.90M3.52MN/A1.77M815.00K
Gross Profit4.75M4.48M3.99M6.56M8.33M8.88M7.31M5.67M7.21M7.29M8.40M10.74M8.71M6.14M3.88M2.80M1.08M1.54M-2.32M-2.17MN/A702.00K1.19M
Operating Expenses9.45M9.05M9.88M10.01M15.00M20.14M21.50M18.64M17.36M13.95M14.45M14.12M15.18M13.65M11.89M20.11M23.51M21.03M18.53M14.15MN/A2.17M1.33M
Selling, General & Admin7.58M8.84M9.76M9.45M13.66M18.62M19.92M17.07M15.56M12.41M11.56M11.89M13.20M11.60M9.90M13.86M13.73M16.52M15.93M12.49MN/A2.10M1.33M
Research & Development1.87M207.00K125.00K555.00K1.34M1.52M1.57M1.58M1.81M1.53M2.89M2.22M1.98M2.05M2.00M6.25M9.78M4.51M2.60M1.65MN/A68.00K6.00K
Other Operating Expenses-330.00K-631.00K-394.00K-594.00K240.00K-239.00KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Income-4.70M-4.57M-5.89M-3.45M-6.67M-11.26M-14.19M-12.97M-10.15M-6.66M-6.05M-3.37M-6.47M-7.50M-8.02M-17.31M-22.43M-19.48M-20.85M-16.31M902.00K-1.47M-147.00K
Other Expenses / Income-330.00K-614.00K469.00K-453.00K3.85M-239.00K-139.00K37.00K-10.00K-1.54M9.79M-2.06M65.00K-40.00K-209.00K-64.00K2.47M345.00K-377.00K146.00KN/A-4.00K4.00K
Before Tax Income-5.03M-5.18M-5.42M-3.90M-2.83M-11.34M-14.33M-12.94M-10.16M-8.20M3.73M-5.43MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Income Tax Expenses-196.00K-33.00K-332.00K713.00K121.00K458.00KN/A-4.27MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Net Income-4.83M-5.15M-5.09M-4.62M-2.95M-11.80M-14.33M9.27M-10.16M-8.20M3.73M-5.43M-7.33M-7.95M-8.23M-17.66M-20.34M-19.78M-23.10M-16.53M-7.30M-1.59M-167.00K
Interest ExpensesN/A16.00K-10.00K12.00K16.00K33.00K40.00K3.00K3.00K3.00K1.06M1.11M931.00K406.00K9.00K437.00KN/AN/AN/AN/AN/AN/AN/A
Basic Shares Outstanding9.09M3.39M2.65M2.00M1.48M924.00K503.33K474.44K365.42K214.60K152.93K110.64K86.94K83.73K72.99K51.49K40.43K17.30K13.17K12.43K12.41K12.15K12.05K
Diluted Shares Outstanding9.09M3.39M2.65M2.00M1.48M924.00K503.33K474.44K365.42K214.60K153.29K110.64K86.94K83.73K72.99K51.49K40.43K17.30K13.17K12.43K12.41K12.15K12.05K
EBITDA-4.53M-4.45M-6.57M-3.80M-6.07M-10.85M-13.80M5.26M-9.91M-7.95M5.08M-4.06M-6.07M-7.15M-7.79M-16.45M-19.60M-19.11M-22.45M-16.10M-7.14M-1.59M-167.00K
EBITDA Margin-35.53%-33.50%-52.06%-20.40%-32.05%-57.22%-82.83%40.99%-65.73%-57.36%37.15%-26.25%-47.65%-73.27%-105.78%-305.33%-511.06%-420.67%-868.73%-1,187.02%-791.35%-64.57%-8.35%
EBIT-5.03M-5.17M-5.43M-3.89M-2.81M-11.31M-14.29M5.01M-10.16M-8.20M4.79M-4.32M-6.40M-7.54M-8.22M-17.22M-20.34M-19.78M-23.10M-16.53M-7.30M-1.59M-167.00K
EBIT Margin-39.51%-38.94%-42.98%-20.88%-14.83%-59.60%-85.77%39.06%-67.35%-59.19%35.07%-27.98%-50.20%-77.32%-111.66%-319.58%-530.35%-435.46%-893.92%-1,219.03%-809.09%-64.57%-8.35%
Financial Year End2024-03-312023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-312012-03-312011-03-312010-03-312009-03-312008-03-312007-03-312006-03-312005-03-312004-03-312003-03-312002-03-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙